{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T02:52:17Z","timestamp":1771901537171,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01 IP000662"],"award-info":[{"award-number":["U01 IP000662"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 RR024153"],"award-info":[{"award-number":["UL1 RR024153"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000005"],"award-info":[{"award-number":["UL1TR000005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI116575"],"award-info":[{"award-number":["R01 AI116575"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-2967-2","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T13:04:49Z","timestamp":1516885489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cost-effectiveness of increasing vaccination in high-risk adults aged 18\u201364\u00a0Years: a model-based decision analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Angela R.","family":"Wateska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Patricia","family":"Nowalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8088-566X","authenticated-orcid":false,"given":"Kenneth J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chyongchiou J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"issue":"39","key":"2967_CR1","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1016\/j.vaccine.2010.07.037","volume":"28","author":"RK Zimmerman","year":"2010","unstructured":"Zimmerman RK, Lauderdale DS, Tan SM, Wagener DK. Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine. 2010;28(39):6470\u20137.","journal-title":"Vaccine"},{"key":"2967_CR2","volume-title":"Adult conditions immunization schedule. National Center for Immunization and Respiratory Diseases","author":"Centers for Disease Contol and Prevention","year":"2016","unstructured":"Centers for Disease Contol and Prevention. Adult conditions immunization schedule. National Center for Immunization and Respiratory Diseases. 2016; \n                    http:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult-conditions.html\n                    \n                  . Accesssed 15 June 2016."},{"issue":"1","key":"2967_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6501a1","volume":"65","author":"WW Williams","year":"2016","unstructured":"Williams WW, Lu P-J, O'Halloran A, et al. Surveillance of vaccination coverage among adult populations- United States, 2014. MMWR Surveill Summ. 2016;65(1):1\u201340.","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"2967_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/jgs.14451","volume":"65","author":"RK Zimmerman","year":"2017","unstructured":"Zimmerman RK, Brown AE, Pavlik VN, et al. Using the 4 pillars practice transformation program to increase pneumococcal immunizations for older adults: a cluster-randomized trial. J Am Geriatr Soc. 2017;65(1):114\u201322.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2967_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12879-016-1940-1","volume":"16","author":"CJ Lin","year":"2016","unstructured":"Lin CJ, Nowalk MP, Pavlik VN, et al. Using the 4 pillars\u2122 practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial. BMC Inf Dis. 2016;16(1):623.","journal-title":"BMC Inf Dis."},{"issue":"41","key":"2967_CR6","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1016\/j.vaccine.2016.07.053","volume":"34","author":"MP Nowalk","year":"2016","unstructured":"Nowalk MP, Lin CJ, Pavlik VN, et al. Using the 4 pillars\u2122 practice transformation program to increase adult Tdap immunization in a randomized controlled cluster trial. Vaccine. 2016;34(41):5026\u201333.","journal-title":"Vaccine"},{"issue":"6","key":"2967_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jhq.12020","volume":"36","author":"MP Nowalk","year":"2014","unstructured":"Nowalk MP, Bolan N, Nutini J, et al. Success of the 4 pillars toolkit for influenza and pneumococcal vaccination in adults. J Healthc Qual. 2014;36(6):5\u201315.","journal-title":"J Healthc Qual"},{"issue":"29","key":"2967_CR8","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1016\/j.vaccine.2014.04.057","volume":"32","author":"RK Zimmerman","year":"2014","unstructured":"Zimmerman RK, Nowalk MP, Lin CJ, et al. Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care. Vaccine. 2014;32(29):3656\u201363.","journal-title":"Vaccine"},{"issue":"4","key":"2967_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/jgs.14588","volume":"65","author":"KJ Smith","year":"2017","unstructured":"Smith KJ, Zimmerman RK, Nowalk MP, Lin CJ. Cost-effectiveness of the 4 pillars practice Transormation program to improve vaccination of adults aged 65 and older. J Am Geriat Soc. 2017;65(4):763\u201378.","journal-title":"J Am Geriat Soc"},{"issue":"8","key":"2967_CR10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/jama.2012.169","volume":"307","author":"KJ Smith","year":"2012","unstructured":"Smith KJ, Wateska AR, Nowalk MP, Raymund M, Nuorti JP, Zimmerman RK. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA. 2012;307(8):804\u201312.","journal-title":"JAMA"},{"key":"2967_CR11","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","volume":"372","author":"MJM Bonten","year":"2015","unstructured":"Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. New Engl J Med. 2015;372:1114\u201325.","journal-title":"New Engl J Med"},{"issue":"27","key":"2967_CR12","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","volume":"25","author":"N-AM Molinari","year":"2007","unstructured":"Molinari N-AM, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086\u201396.","journal-title":"Vaccine"},{"key":"2967_CR13","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1016\/j.vaccine.2012.05.076","volume":"30","author":"D Weycker","year":"2012","unstructured":"Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged \u2265 50 years. Vaccine. 2012;30:5437\u201344.","journal-title":"Vaccine"},{"issue":"1","key":"2967_CR14","doi-asserted-by":"publisher","first-page":"e72723","DOI":"10.1371\/journal.pone.0072723","volume":"9","author":"LJ McGarry","year":"2014","unstructured":"McGarry LJ, Krishnarajah G, Hill G, et al. Cost-effectiveness of tdap vaccination of adults aged \u226565 years in the prevention of pertussis in the US: a dynamic model of disease transmission. PLoS One. 2014;9(1):e72723.","journal-title":"PLoS One"},{"issue":"1","key":"2967_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12879-015-1269-1","volume":"15","author":"C Masseria","year":"2015","unstructured":"Masseria C, Krishnarajah G. The estimated incidence of pertussis in people aged 50 years old in the United States, 2006\u20132010. BMC Inf Dis. 2015;15(1):534.","journal-title":"BMC Inf Dis"},{"key":"2967_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","volume":"15","author":"MR Moore","year":"2015","unstructured":"Moore MR, Link-Gelles R, Schaffner W, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15:301\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"2967_CR17","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1542\/peds.2004-2509","volume":"115","author":"GM Lee","year":"2005","unstructured":"Lee GM, LeBaron C, Murphy TV, Lett S, Schauer S, Lieu TA. Pertussis in adolescents and adults: should we vaccinate? Pediatrics. 2005;115(6):1675\u201384.","journal-title":"Pediatrics"},{"issue":"11","key":"2967_CR18","first-page":"1","volume":"64","author":"E Arias","year":"2015","unstructured":"Arias E. United States life tables, 2011. Natl Vital Stat Rep. 2015;64(11):1\u201363.","journal-title":"Natl Vital Stat Rep"},{"issue":"10","key":"2967_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"GD Sanders","year":"2016","unstructured":"Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093\u2013103.","journal-title":"JAMA"},{"issue":"9","key":"2967_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1056\/NEJMp1405158","volume":"371","author":"PJ Neumann","year":"2014","unstructured":"Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness - the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371(9):796\u20137.","journal-title":"N Engl J Med"},{"key":"2967_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/1471-2458-14-718","volume":"14","author":"CI Michaelidis","year":"2014","unstructured":"Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States. BMC Public Health. 2014;14:718.","journal-title":"BMC Public Health"},{"issue":"2","key":"2967_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jval.2012.11.009","volume":"16","author":"CI Michaelidis","year":"2013","unstructured":"Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Cost-effectiveness of a program to eliminate disparities in pneumococcal vaccination rates in elderly minority populations: an exploratory analysis. Value Health. 2013;16(2):311\u20137.","journal-title":"Value Health"},{"issue":"19","key":"2967_CR23","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1016\/j.vaccine.2011.02.098","volume":"29","author":"CI Michaelidis","year":"2011","unstructured":"Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups. Vaccine. 2011;29(19):3525\u201330.","journal-title":"Vaccine"},{"key":"2967_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.vaccine.2016.11.018","volume":"35","author":"RK Zimmerman","year":"2017","unstructured":"Zimmerman RK, Moehling KK, Lin CJ, et al. Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 pillars\u2122 practice transformation program. Vaccine. 2017;35:109\u201317.","journal-title":"Vaccine"},{"issue":"3","key":"2967_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/JHQ.0000000000000071","volume":"39","author":"M Hawk","year":"2017","unstructured":"Hawk M, Nowalk MP, Moehling KK, et al. Using a mixed methods approach to examine practice characteristics associated with implementation of an adult immunization intervention using the 4 pillars practice transformation program. J Healthc Qual. 2017;39(3):153\u201367.","journal-title":"J Healthc Qual"},{"issue":"1","key":"2967_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.acap.2015.03.010","volume":"16","author":"MP Nowalk","year":"2016","unstructured":"Nowalk MP, Zimmerman RK, Lin CJ, et al. Maintenance of increased childhood influenza vaccination rates 1 year after an intervention in primary care practices. Acad Pediatr. 2016;16(1):57\u201363.","journal-title":"Acad Pediatr"},{"key":"2967_CR27","first-page":"CD000422","volume":"1","author":"S Moberley","year":"2013","unstructured":"Moberley S, Holden J, Tatham D, Andrews R. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;1:CD000422.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2967_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","volume":"12","author":"MT Osterholm","year":"2012","unstructured":"Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36\u201344.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"2967_CR29","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/infdis\/jiu322","volume":"210","author":"R Koepke","year":"2014","unstructured":"Koepke R, Eickhoff JC, Ayele RA, et al. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by tdap brand. J Infect Dis. 2014;210(6):942\u201353.","journal-title":"J Infect Dis"},{"key":"2967_CR30","unstructured":"CDC Vaccine Price List. Centers for Disease Control and Prevention. \n                    http:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/\n                    \n                  . Accessed 26 May 2016."},{"key":"2967_CR31","unstructured":"Centers for Medicare & Medicaid Services. Physician fee schedule search. \n                    www.cms.gov\/apps\/physician-fee-schedule\/search\/search-criteria.aspx\n                    \n                  . Accessed 15 Oct 2015."},{"issue":"12","key":"2967_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.7326\/0003-4819-138-12-200306170-00007","volume":"138","author":"JE Sisk","year":"2003","unstructured":"Sisk JE, Whang W, Butler JC, Sneller V-P, Whitney CG. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race. Ann Intern Med. 2003;138(12):960\u20138.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2967_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","volume":"36","author":"MR Gold","year":"1998","unstructured":"Gold MR, Franks P, McCoy K, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care. 1998;36(6):778\u201392.","journal-title":"Med Care"},{"issue":"8","key":"2967_CR34","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s11606-016-3651-0","volume":"31","author":"C Stoecker","year":"2016","unstructured":"Stoecker C, Kim L, Gierke R, Pilishvili T. Incremental cost-effectiveness of 13-valent pneumococcal conjugate vaccine for adults age 50 years and older in the United States. J Gen Intern Med. 2016;31(8):901\u20138.","journal-title":"J Gen Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-2967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-2967-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-2967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:27:20Z","timestamp":1589455640000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-2967-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2967"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-2967-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"10 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Most data used in the model came from publically available and\/or published data; use of this data is exempt from ethics review in the U.S. . However some data came from the 4 Pillars cluster randomized trial. In that study, standard informed consent procedures were followed, and trial protocols were approved by institutional review boards of the University of Pittsburgh, Baylor College of Medicine, and the Harris Health System.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Zimmerman and Dr. Lin have active research grants from Sanofi Pasteur, Merck & Co., Inc., and Pfizer Inc. Dr. Nowalk has received or currently receives grant funding from Merck & Co., Inc., Pfizer, Inc., and MedImmune, LLC. All other authors have no competing interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"52"}}